L’avis intitulé « Vaccin antigrippal EFLUELDA : transition du vaccin antigrippal EFLUELDA, de sa forme quadrivalente à une forme trivalente, dans la stratégie de vaccination contre la grippe saisonnière », ci-joint, est adopté.
Voir aussi
Recommandation vaccinale
13/02/2025
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
764CRdq4F0L2CGM2
